Modulators of Cystic Fibrosis Transmembrane Conductance Regulator

This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulato...

Full description

Saved in:
Bibliographic Details
Main Authors HADIDA RUAH, SARA SABINA, BOOKSER, BRETT C, GALLANT, MICHEL, STURINO, CLAUDIO, REDDY, THUMKUNTA JAGADEESWAR, ZHOU, JINGLAN, PARASELLI, PRASUNA, RAMTOHUL, YEEMAN K, COON, TIMOTHY R, CLEVELAND, THOMAS, MELILLO, VITO, VALDEZ, LINO, LATERREUR, JULIE, GROOTENHUIS, PETER, CLEMENS, JEREMY J, MILLER, MARK THOMAS
Format Patent
LanguageChinese
English
Published 01.06.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulators.
Bibliography:Application Number: TW202110129327